Section Arrow
CELU.NASDAQ
- Celularity
(Financial Status)
Quotes are at least 15-min delayed:2025/07/17 16:44 EDT
After Hours
Last
 2.22
+0.02 (+0.91%)
Bid
2.14
Ask
2.23
High 2.36 
Low 2.15 
Volume 3195 
Regular Hours
Last
 2.2
+0.06 (+2.80%)
Day High 
2.25 
Prev. Close
2.14 
1-M High
2.66 
Volume 
136.95K 
Bid
2.14
Ask
2.23
Day Low
2.0319 
Open
2.16 
1-M Low
1.7184 
Market Cap 
51.25M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.1 
20-SMA 1.99 
50-SMA 1.99 
52-W High 5.22 
52-W Low 1.0007 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.64/-0.42
Enterprise Value
113.73M
Balance Sheet
Book Value Per Share
0.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
22.77M
Operating Revenue Per Share
0.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
WINTWindtree Therapeutics Inc.1.05+0.15+16.67%0.84PE
After Hours 1.1 +0.05 +4.76%
ABPAbpro Holdings Inc0.1962-0.022-10.08%-- 
After Hours 0.1955 -0.0007 -0.36%
NCNANuCana plc0.0468-0.0034-6.77%-- 
After Hours 0.04685 +0.00005 +0.11%
ATNF180 Life Sciences Corp1.83+0.9497+107.88%0.11PE
After Hours 1.7105 -0.1195 -6.53%
MRKRMarker Therapeutics1.92+0.32+20.00%-- 
After Hours 1.92 0 0.00%
Quotes are at least 15-min delayed:2025/07/17 16:44 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.